losoxantrone has been researched along with Breast Cancer in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandra, L; Higginson, LA; Huan, SD; Veinot, JP; Walley, VM; Walsh, SM | 1 |
| Kaufman, PA | 1 |
| Hortobagyi, GN | 1 |
| Fisher, GR; Patterson, LH | 1 |
| Ashley, SE; Calvert, AH; Judson, I; Mansi, JL; Smith, IE; Talbot, DC | 1 |
1 review(s) available for losoxantrone and Breast Cancer
| Article | Year |
|---|---|
Paclitaxel and anthracycline combination chemotherapy for metastatic breast cancer.
Topics: Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Humans; Neoplasm Metastasis; Paclitaxel; Pyrazoles; Pyrazolones; Randomized Controlled Trials as Topic | 1999 |
1 trial(s) available for losoxantrone and Breast Cancer
| Article | Year |
|---|---|
Anthrapyrazole CI941: a highly active new agent in the treatment of advanced breast cancer.
Topics: Adult; Aged; Anthraquinones; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Female; Heart Diseases; Humans; Injections, Intravenous; Leukopenia; Life Tables; Middle Aged; Poisson Distribution; Pyrazoles; Pyrazolones | 1991 |
3 other study(ies) available for losoxantrone and Breast Cancer
| Article | Year |
|---|---|
Potential cardiotoxicity with the use of DuP-941: a case report.
Topics: Adult; Anthraquinones; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Fatal Outcome; Female; Heart; Heart Failure; Humans; Lung Neoplasms; Lymphatic Metastasis; Mastectomy; Microscopy, Electron; Myocardium; Myofibrils; Pyrazoles; Pyrazolones | 1995 |
Overview of new treatments for breast cancer.
Topics: Animals; Anthraquinones; Antibodies, Monoclonal; Antineoplastic Agents; Bone Marrow Diseases; Breast Neoplasms; Drug Design; Drug Screening Assays, Antitumor; Hormone Antagonists; Humans; Immunologic Factors; Paclitaxel; Pyrazoles; Pyrazolones; Survival Analysis; Vinblastine; Vinorelbine | 1992 |
Lack of involvement of reactive oxygen in the cytotoxicity of mitoxantrone, CI941 and ametantrone in MCF-7 cells: comparison with doxorubicin.
Topics: Anthraquinones; Antineoplastic Agents; Breast Neoplasms; Cell Death; DNA, Neoplasm; Doxorubicin; Humans; Mitoxantrone; Oxidation-Reduction; Pyrazoles; Pyrazolones; Reactive Oxygen Species; Tumor Cells, Cultured | 1992 |